Why the Certificate of Analysis Matters in Peptide Research
When a vial of synthetic peptide arrives in the laboratory, the Certificate of Analysis (COA) is the primary document linking the material inside the vial to the analytical data generated during its manufacture. For researchers designing dose-response experiments, receptor-binding assays, or cell-based studies, every quantitative result ultimately depends on knowing the actual composition of the compound being used. A COA that is read superficially—or ignored entirely—introduces systematic errors that can propagate through an entire dataset. Understanding each field of the document is therefore a foundational laboratory skill, not an administrative formality.
Identifying Basic Product Information
The top section of any well-structured COA contains product identifiers that should be verified before the document is read further. Key fields include:
- Peptide name and sequence: The full one-letter or three-letter amino acid sequence should be listed explicitly. Confirm that the sequence matches your purchase order and any published reference sequence you are working from.
- Molecular formula and molecular weight: These are calculated from the sequence and any modifications (e.g., amidated C-terminus, acetylated N-terminus, disulfide bridges). Cross-reference the molecular weight against a trusted sequence calculator to catch transcription errors.
- Lot or batch number: This number links the vial to a specific manufacturing run and to all associated raw analytical data. Always record this number in your laboratory notebook alongside experimental results.
- Catalog number: Ensures traceability if the same peptide is reordered and a new lot is used in later experiments.
- Net weight or quantity: Expressed in milligrams or micrograms, this figure is needed for accurate stock solution preparation. Note that this is the gross weight of the lyophilized powder, which includes residual water and counterions—a point addressed in the moisture section below.
Purity: The HPLC Section
Purity by reverse-phase high-performance liquid chromatography (RP-HPLC) is the most prominently reported quality metric on a peptide COA, and it is frequently misunderstood. The reported percentage—commonly expressed as area percent at 214 nm or 220 nm UV absorbance—reflects the chromatographic peak area of the target peptide relative to all integrated peaks in the chromatogram. It does not represent weight-for-weight purity, and it does not account for UV-silent impurities such as water, residual solvents, trifluoroacetic acid (TFA) counterion, or inorganic salts.
For most research applications, a purity threshold of ≥95% by HPLC is considered appropriate. Peptides reported at 98% or higher are suitable for experiments where impurity-related artifacts would be particularly problematic, such as immunological assays or structural studies. Peptides in the 90–95% range may be acceptable for preliminary screening but should be used with awareness that minor peaks in the chromatogram represent structurally related deletion sequences, oxidation products, or incomplete deprotection by-products.
When reviewing the chromatogram itself (many suppliers provide it as an attachment or embedded image), look for baseline separation of the main peak from neighboring peaks, symmetry of the principal peak, and the integration method used. A single broad asymmetric peak that has been integrated as one entity can artificially inflate the reported purity figure.
Identity Confirmation: Mass Spectrometry Data
HPLC purity tells you how much of the material in the vial is the dominant species, but it does not confirm which species that is. Mass spectrometry (MS) provides the identity confirmation. On a COA, this section typically reports:
- Expected molecular weight (MW): Calculated from the sequence and modifications, usually presented as the monoisotopic or average mass.
- Observed m/z values: The instrument detects multiply charged ions; the COA should show at least one charge state (e.g., [M+2H]²⁺, [M+3H]³⁺) from which the neutral mass can be back-calculated.
- Calculated neutral mass vs. observed neutral mass: These two numbers should agree within the instrument's mass accuracy, typically ±0.1–1 Da for electrospray ionization (ESI) instruments, or within a few parts per million on high-resolution instruments.
A discrepancy between expected and observed mass is a serious flag. Common causes include incorrect sequence synthesis, incomplete removal of protecting groups (each adds a characteristic mass increment), oxidation of methionine or tryptophan residues (+16 Da per event), or cyclization artifacts. If the observed mass does not match expectation, the material should not be used without further investigation.
Water and Residual Solvent Content
Because lyophilized peptides are hygroscopic and because the TFA counterion contributes mass, the net weight on the label overstates the actual peptide content. A thorough COA will report moisture content determined by Karl Fischer titration and may report TFA content measured by ion chromatography or 19F NMR. These values allow calculation of a peptide content correction factor—the true mass fraction of intact peptide in the bulk powder.
For example, a peptide powder with 8% moisture and 12% TFA by mass contains only approximately 80% actual peptide by weight. If a researcher dissolves 1 mg of such powder assuming 100% peptide content, the true peptide concentration in the resulting solution will be meaningfully lower than intended. In quantitative assays, failing to apply this correction introduces a consistent negative bias into all concentration-dependent measurements.
Sterility and Endotoxin Testing
Research peptides are not manufactured under pharmaceutical GMP conditions and are explicitly not intended for administration to humans or animals. However, cell-based assays using sensitive primary cultures or immortalized lines can be confounded by bacterial endotoxins (lipopolysaccharide, LPS). Some COAs include a limulus amebocyte lysate (LAL) endotoxin test result expressed in endotoxin units per milligram (EU/mg). When working with macrophages, dendritic cells, or other innate immune effector cells, reviewing and recording this value is important for experimental interpretation.
Storage Conditions and Retest Date
The COA should specify recommended storage conditions—typically −20 °C for most lyophilized peptides, with protection from light for photosensitive residues such as tryptophan or tyrosine derivatives. A retest date or expiry date indicates the period within which the supplier guarantees the analytical data remain representative of the material. Beyond this date, re-analysis by the researcher's own laboratory or by a contract analytical service is advisable before using the peptide in critical experiments.
Building a Documentation Habit
Good research practice requires that the COA be filed alongside the corresponding experimental records. When a publication or internal report cites a peptide, the lot number and purity should be reportable. This documentation enables retrospective troubleshooting if results become inconsistent across experiments and supports reproducibility when collaborators or other laboratories attempt to replicate the work.
In summary, a COA is a multi-dimensional quality document. Reading it critically—verifying sequence identity, understanding HPLC purity limitations, applying moisture corrections, and confirming mass spectrometric identity—transforms it from a compliance checkbox into a genuine tool for experimental rigor.
For research use only. The information presented in this article is intended solely for qualified laboratory researchers working with research-grade peptides in non-clinical, in vitro or preclinical settings. Nothing in this article constitutes medical advice, therapeutic guidance, or dosing information of any kind.